Rosa Vila-Olives, Aitor Uribarri, María Martínez-Martínez, Eduard Argudo, Camilo Bonilla, Luis Chiscano, Lorena Herrador, Alejandra Gabaldón, Irene Buera, Maria Vidal, Ana De la Iglesia, Maria Ángeles Díaz, Elena López, Marta Font, Jose A Barrabés, Jordi Riera, Ignacio Ferreira-González, Ricard Ferrer
INTRODUCTION: Cases of myocarditis after COVID-19 messenger RNA (mRNA) vaccines administration have been reported. Although the majority follow a mild course, fulminant presentations may occur. In these cases, cardiopulmonary support with venoarterial extracorporeal membrane oxygenation (V-A ECMO) may be needed. RESULTS: We present two cases supported with V-A ECMO for refractory cardiogenic shock due to myocarditis secondary to a mRNA SARS-CoV2 vaccine. One of the cases was admitted for out-of-hospital cardiac arrest...
April 19, 2023: Perfusion